CareDx, Inc
NASDAQ Global MarketTotal Valuation
CareDx, Inc carries a market capitalization of 1.19B, placing it among publicly traded companies globally. Its enterprise value stands at 744.77M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.19B |
| Enterprise Value | 744.77M |
Share Statistics
CareDx, Inc currently has 51.27M shares outstanding.
| Shares Outstanding | 51.27M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
CareDx, Inc trades at a trailing price-to-earnings ratio of 34.80. The price-to-sales ratio is 2.20, and the price-to-book ratio stands at -1.24.
| PE Ratio | 34.80 |
| PS Ratio | 2.20 |
| PB Ratio | -1.24 |
| P/TBV Ratio | 3.76 |
| P/FCF Ratio | 12.00 |
| P/OCF Ratio | 12.44 |
Enterprise Valuation
On an enterprise value basis, CareDx, Inc trades at an EV/EBITDA multiple of 134.56 and an EV/FCF ratio of 9.70.
| EV / Sales | 1.80 |
| EV / EBITDA | 134.56 |
| EV / EBIT | N/A |
| EV / FCF | 9.70 |
Financial Position
CareDx, Inc maintains a current ratio of 3.40, meaning it holds 3.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.40 |
| Quick Ratio | 2.93 |
| Debt / Equity | 7.81 |
| Debt / EBITDA | 4.43 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -1.82 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 5.21 |
Taxes
| Income Tax | 181,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
CareDx, Inc's stock has gained approximately 20.45097% over the past 52 weeks. The 50-day moving average sits at 20.86, while the 200-day moving average is 18.13.
| Beta (5Y) | N/A |
| 52-Week Price Change | 20.45097% |
| 50-Day Moving Average | 20.86 |
| 200-Day Moving Average | 18.13 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, CareDx, Inc generated 412.82M in revenue and converted that into -8.19M in net income, yielding earnings per share of -0.15. EBITDA reached 5.54M, while operating income came in at -15.26M.
| Revenue | 412.82M |
| Gross Profit | 284.37M |
| Operating Income | -15.26M |
| Pretax Income | -8.01M |
| Net Income | -8.19M |
| EBITDA | 5.54M |
| EBIT | -15.26M |
| Earnings Per Share (EPS) | -0.15 |
Balance Sheet
CareDx, Inc holds 187.18M in cash and equivalents against 24.50M in total debt, resulting in a net debt position of -77.92M. Total book value stands at -732.50M, with working capital of 190.24M providing operational flexibility.
| Cash & Cash Equivalents | 187.18M |
| Total Debt | 24.50M |
| Net Debt | -77.92M |
| Equity (Book Value) | -732.50M |
| Book Value Per Share | -14.01 |
| Working Capital | 190.24M |
Cash Flow
CareDx, Inc produced 72.95M in operating cash flow over the past twelve months. After subtracting -3.82M in capital expenditures, free cash flow totaled 69.13M - equivalent to 1.32 per share.
| Operating Cash Flow | 72.95M |
| Capital Expenditures | -3.82M |
| Free Cash Flow | 69.13M |
| FCF Per Share | 1.32 |
Margins
CareDx, Inc operates with a gross margin of 68.88, reflecting its pricing power and cost economics. The operating margin of -3.70 and net profit margin of -1.98 provide insight into operational efficiency.
| Gross Margin | 68.88 |
| Operating Margin | -3.70 |
| Pretax Margin | -1.94 |
| Profit Margin | -1.98 |
| EBITDA Margin | 1.34 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 10.54 |
| FCF Yield | 8.33 |
Scores
CareDx, Inc posts an Altman Z-Score of 4.30, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.30 |